The Hospital Clínic Barcelona has successfully performed the first surgeries with Bitrack, the surgical robot created by the Catalan company, Rob Surgical. The first surgeries were three radical nephrectomies and all three surgeries were performed satisfactorily, and, after a 30-day follow-up, no adverse events were observed as a result of the use of the Bitrack system.
This series of operations is the first step in the clinical validation of the robot’s safety and efficacy for kidney surgery after numerous tests on animal models, which were carried out in collaboration with Specipig (Contract Research Organization focused on the pig model), and on corpse models carried out by CMCiB (Comparative Medicine and Bioimage Centre) at the Germans Trias i Pujol research centre (IGTP). All parts, including Rob Surgical, are CataloniaBio & HealthTech members. Surgeons from the Mayo Clinic (USA), the Hospital Clínic University Hospital, the Vall d'Hebron University Hospital and the Germans Trias i Pujol University Hospital participated in the preclinical phase.
The ultimate goal of this patient trial is to certify the robot and start marketing it in 2024. Rob Surgical is the 8th company in the world and the 1st in Spain to obtain authorization to carry out clinical trials in patients with urological diseases.
Bitrack, the only open-platform surgical robot, is the result of over 10 years of research. One of this robot’s differentiating factors is the possibility of performing hybrid surgeries, which allow the surgeon to combine manual manoeuvres (MIS) and robotic methods (MIRS). All this thanks to the use of the same instruments and flexible robotics that allow the robot to intervene onlyin the most delicate parts.
“This new milestone brings the medical robotics technology company closer to its founding purpose: to universalize precision surgery and bring its benefits to all hospitals, surgeons and patients around the world. Moreover, this success is the prelude to the market launch”, points out Jaume Amat, CEO of Rob Surgical.
After the completion of the first series in humans, Rob Surgical will continue working with the Hospital Clínic Barcelona Urology Service on the optimization of the system and the clinical introduction of the Bitrack surgical robot to bring the benefits of precision surgery to all patients in this field. Likewise, Rob Surgical will continue to work in the fields of General Surgery and Gynaecology.
Comments